Aromatase inhibitors in post-menopausal metastatic breast carcinoma.

about

Aromatase inhibitors in post-menopausal metastatic breast carcinoma.

Item

http://www.wikidata.org/entity/Q36861597

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Aromatase inhibitors in post-menopausal metastatic breast carcinoma.

@en

type

Item

label

Aromatase inhibitors in post-menopausal metastatic breast carcinoma.

@en

prefLabel

Aromatase inhibitors in post-menopausal metastatic breast carcinoma.

@en

P1476

Aromatase inhibitors in post-menopausal metastatic breast carcinoma.

@en

P2093

Alain Gelibter

http://www.w3.org/2001/XMLSchema#string

Alessandra Fabi

http://www.w3.org/2001/XMLSchema#string

Alessandra Felici

http://www.w3.org/2001/XMLSchema#string

Carmen Nuzzo

http://www.w3.org/2001/XMLSchema#string

Cecilia Nisticò

http://www.w3.org/2001/XMLSchema#string

Edmondo Terzoli

http://www.w3.org/2001/XMLSchema#string

Enzo Maria Ruggeri

http://www.w3.org/2001/XMLSchema#string

Fabiana Letizia Cecere

http://www.w3.org/2001/XMLSchema#string

Federica Cuppone

http://www.w3.org/2001/XMLSchema#string

Francesco Cognetti

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic inactivation of estrogens in breast tissue by UDP-glucuronosyltransferase enzymes: an overview.

Endocrinology and hormone therapy in breast cancer: aromatase inhibitors versus antioestrogens

Estrogen production and action

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

Adaptive hypersensitivity to estrogen: mechanism for sequential responses to hormonal therapy in breast cancer.

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma: results of a survival update based on a combined analysis of data from two mature phase III trials. Arimidex Study Group.

Survival with aromatase inhibitors and inactivators versus standard hormonal therapy in advanced breast cancer: meta-analysis.

Cross-resistance to different aromatase inhibitors in breast cancer treatment.

P304

1023-1036

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543784.16.7.1023

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Diana Giannarelli

Emilio Bria

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17594187

http://www.w3.org/2001/XMLSchema#string